Epilepsy & acute bipolar mania treatment | Depakote® (divalproex sodium)

Time 2020-12-07 11:03:59

Web Name: Epilepsy & acute bipolar mania treatment | Depakote® (divalproex sodium)

WebSite: http://www.depakote.com

ID:126427

Keywords:

bipolar,mania,Epilepsy,

Description:

PAY AS LITTLE AS$5/MONTH* Join the nearly 7 out of 10 patients that pay the same or less than the generic when they use the Depakote Savings Card1 GET WHAT YOU ARE PRESCRIBED By having your doctor add Dispense as Written to your prescription†, your pharmacist will fill your prescription with the brand specified. Download your Depakote Savings Card now Text SAVE to 58752 Or download here HELP SAVE TRIPS TO THE PHARMACY Converting a 30-day to a 90-day prescription may save trips to the pharmacy. Ask your doctor. *Up to $100/month savings for eligible patients. Or your state s legal language. By texting SAVE from your phone to the above number, you confirm that you are 18 years of age or older and consent to receive recurring text messages from AbbVie, including service updates, medication reminders, and marketing messages. Message and data rates may apply. Your consent is not a condition of receiving goods or services. You can reply HELP for help or text STOP to unsubscribe at any time. ELIGIBILITY Available to patients with commercial prescription insurance coverage for Depakote who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Depakote Savings Card and patient must call OPUS Health at 800.364.4767 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the Depakote Savings Card from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions. TERMS AND CONDITIONS Pharmacist Instructions Submit the copay card authorized for all commercially insured patients by the patient s primary insurance as a secondary transaction to OPUS Health. When you use this card, you are confirming that you have not submitted and will not submit a claim for this prescription for reimbursement under any federal, state, or government-funded healthcare program, such as Medicare (including Part D), Medicare Advantage, Medicaid, Medigap, Veterans Affairs, the Department of Defense, or TRICARE. Pharmacists with questions please call OPUS Health at 800.364.4767. WHAT IS DEPAKOTE USED FOR?2-4 DEPAKOTE comes in different dosage forms. DEPAKOTE (divalproex sodium) delayed-release tablets, for oral use, and DEPAKOTE ER (divalproex sodium) extended-release tablets, for oral use, are prescription medications used: to treat manic episodes associated with bipolar disorder alone or with other medicines to treat: complex partial seizures in adults and children 10 years of age and older simple and complex absence seizures, with or without other seizure types DEPAKOTE Sprinkle Capsules (divalproex sodium delayed release capsules), for oral use, is a prescription medicine used alone or with other medicines to treat: complex partial seizures in adults and children 10 years of age and older simple and complex absence seizures, with or without other seizure types IMPORTANT SAFETY INFORMATION2-4 The most important information about DEPAKOTE is: Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems. DEPAKOTE can cause serious side effects, including: Serious liver damage that can cause death, especially in children younger than 2 years old. The risk of getting this serious liver damage is more likely to happen within the first 6 months of treatment. In some cases, liver damage may continue despite stopping the drug. Call your healthcare provider right away if you get any of the following symptoms: nausea or vomiting that does not go away, loss of appetite, pain on the right side of your stomach (abdomen), dark urine, swelling of your face, or yellowing of your skin or the whites of your eyes. DEPAKOTE may harm your unborn baby. If you take DEPAKOTE during pregnancy for any medical condition, your baby is at risk for serious birth defects that affect the brain and spinal cord and are called spina bifida or neural tube defects. These defects occur in 1 to 2 out of every 100 babies born to mothers who use this medicine during pregnancy. These defects can begin in the first month, even before you know you are pregnant. Other birth defects that affect the structures of the heart, head, arms, legs, and the opening where the urine comes out (urethra) on the bottom of the penis can also happen. Birth defects may occur even in children born to women who are not taking any medicines and do not have other risk factors. Taking folic acid supplements before getting pregnant and during early pregnancy can lower the chance of having a baby with a neural tube defect. If you take DEPAKOTE during pregnancy for any medical condition, your child is at risk for having a lower IQ and may be at risk for developing autism or attention-deficit/hyperactivity disorder. There may be other medicines to treat your condition that have a lower chance of causing birth defects, decreased IQ, or other disorders in your child. Women who are pregnant must not take DEPAKOTE to prevent migraine headaches. All women of childbearing age (including girls from the start of puberty) should talk to their healthcare provider about using other possible treatments instead of DEPAKOTE. If the decision is made to use DEPAKOTE, you should use effective birth control (contraception). Tell your healthcare provider right away if you become pregnant while taking DEPAKOTE. You and your healthcare provider should decide if you will continue to take DEPAKOTE while you are pregnant. Pregnancy Registry: If you become pregnant while taking DEPAKOTE, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. You can enroll in this registry by calling toll-free 1-888-233-2334 or by visiting the website, www.aedpregnancyregistry.org. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. Inflammation of your pancreas that can cause death. Call your healthcare provider right away if you have any of these symptoms: severe stomach pain that you may also feel in your back, nausea or vomiting that does not go away. Like other antiepileptic drugs, DEPAKOTE may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); new or worse irritability; acting aggressive, being angry, or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); other unusual changes in behavior or mood. How can I watch for early symptoms of suicidal thoughts and actions? Pay attention to any changes, especially sudden changes in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you are worried about symptoms. Do not take DEPAKOTE if you: have liver problems have or think you have a genetic liver problem caused by a mitochondrial disorder (e.g., Alpers Huttenlocher Syndrome) are allergic to divalproex sodium, valproic acid, sodium valproate, or any of the ingredients in DEPAKOTE have a genetic problem called urea cycle disorder are taking it to prevent migraine headaches and are either pregnant or may become pregnant because you are not using effective birth control (contraception) have a genetic liver problem caused by a mitochondrial disorder (e.g., Alpers Huttenlocher Syndrome) drink alcohol are pregnant or breastfeeding since DEPAKOTE can pass into breast milk. Ask your healthcare provider about the best way to feed your baby. have or have had depression, mood problems, or suicidal thoughts or behavior have any other medical condition Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, herbalsupplements. Taking DEPAKOTE with certain other medicines, even for a short period of time, can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider. DEPAKOTE can cause other serious side effects, including: Bleeding problems: red or purple spots on your skin, bruising, pain and swelling into your joints due to bleeding or bleeding from your mouth ornose. High ammonia levels in your blood: feeling tired, vomiting, changes in mental status. Low body temperature (hypothermia): drop in your body temperature to less than 95º F, feeling tired, confusion, coma. Allergic (hypersensitivity) reactions: fever, skin rash, hives, sores in your mouth, blistering and peeling of your skin, swelling of your lymph nodes, swelling of your face, eyes, lips, tongue, or throat, trouble swallowing or breathing. Drowsiness or sleepiness in the elderly. This extreme drowsiness may cause you to eat or drink less than you normally would. Tell your doctor if you are not able to eat or drink as you normally do. Your doctor may start you at a lower dose of DEPAKOTE. Please see the full Prescribing Information, including Medication Guide, for additional information about DEPAKOTE. Talk to your healthcare provider if you have questions. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit Abbvie.com/myAbbVieAssist to learn more. Data on File, AbbVie Inc. IQVIA/LAAD Dataset, September 2019. Depakote Delayed-Release Tablets [package insert]. North Chicago, IL: AbbVie Inc. Depakote ER [package insert]. North Chicago, IL: AbbVie Inc. Depakote Sprinkle Capsules [package insert]. North Chicago, IL: AbbVie Inc. If you have any questions about AbbVie's Depakote.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only, and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of eachpatient. 2020 AbbVie Inc. North Chicago, IL 60064 US-DPKT-200005 July 2020 WHAT IS DEPAKOTE USED FOR?2-4 DEPAKOTE comes in different dosage forms. DEPAKOTE (divalproex sodium) delayed-release tablets, for oral use, and DEPAKOTE ER (divalproex sodium) extended-release tablets, for oral use, are prescription medications used: to treat manic episodes associated with bipolar disorder alone or with other medicines to treat: complex partial seizures in adults and children 10 years of age and older simple and complex absence seizures, with or without other seizure types The most important information about DEPAKOTE is: Do not stop taking DEPAKOTE without first talking to your healthcare provider. Stopping DEPAKOTE suddenly can cause serious problems. DEPAKOTE can cause serious side effects, including: Serious liver damage that can cause death, especially in children younger than 2 years old. The risk of getting this serious liver damage is more likely to happen within the first 6 months of treatment. In some cases, liver damage may continue despite stopping the drug. Call your healthcare provider right away if you get any of the following symptoms: nausea or vomiting that does not go away, loss of appetite, pain on the right side of your stomach (abdomen), dark urine, swelling of your face, or yellowing of your skin or the whites of your eyes. DEPAKOTE may harm your unborn baby. If you take DEPAKOTE during pregnancy for any medical condition, your baby is at risk for serious birth defects that affect the brain and spinal cord and are called spina bifida or neural tube defects. These defects occur in 1 to 2 out of every 100 babies born to mothers who use this medicine during pregnancy. These defects can begin in the first month, even before you know you are pregnant. Other birth defects that affect the structures of the heart, head, arms, legs, and the opening where the urine comes out (urethra) on the bottom of the penis can also happen. Birth defects may occur even in children born to women who are not taking any medicines and do not have other risk factors. Taking folic acid supplements before getting pregnant and during early pregnancy can lower the chance of having a baby with a neural tube defect. If you take DEPAKOTE during pregnancy for any medical condition, your child is at risk for having a lower IQ. There may be other medicines to treat your condition that have a lower chance of causing birth defects, decreased IQ, or other disorders in your child. Women who are pregnant must not take DEPAKOTE to prevent migraine headaches. All women of childbearing age (including girls from the start of puberty) should talk to their healthcare provider about using other possible treatments instead of DEPAKOTE. If the decision is made to use DEPAKOTE, you should use effective birth control (contraception). Tell your healthcare provider right away if you become pregnant while taking DEPAKOTE. You and your healthcare provider should decide if you will continue to take DEPAKOTE while you are pregnant. Pregnancy Registry: If you become pregnant while taking DEPAKOTE, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. You can enroll in this registry by calling toll-free 1-888-233-2334 or by visiting the website, www.aedpregnancyregistry.org. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. Inflammation of your pancreas that can cause death. Call your healthcare provider right away if you have any of these symptoms: severe stomach pain that you may also feel in your back, nausea or vomiting that does not go away. Like other antiepileptic drugs, DEPAKOTE may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); new or worse irritability; acting aggressive, being angry, or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); other unusual changes in behavior or mood. How can I watch for early symptoms of suicidal thoughts and actions? Pay attention to any changes, especially sudden changes in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you are worried about symptoms. You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site s endorsement of Depakote.com or AbbVie. Do you wish to leave this site? You are about to enter a site that is for U.S. Healthcare Professionals only. By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the U.S. but may not be available in all other countries. I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only section of this site. You are leaving the AbbVie website and connecting to the Track It! application on iTunes. This application is not a substitute for seizure safety. Please talk to your doctor for more information on seizure first aid. The Track It! application is not owned by or under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site s endorsement of Depakote.com or AbbVie. Do you wish to leave this site? Private/Commercial Insurance Health insurance that you or a family member obtained through an employer or purchased privately Government-provided Insurance State or federally funded insurance programs such as Medicare (including Part D), Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs I am not insured Submit Based on your answer to the question, you are not eligible to receive the DEPAKOTE SavingsCard. The DEPAKOTE Savings Card is not available to individuals who are paying cash for their prescription or who are receiving prescription reimbursement under a state or federally funded insurance program. Based on your answer to the question, you are not eligible to submit a rebate form for your DEPAKOTE prescription. This rebate form is not available to individuals who are paying cash for their prescription or who are receiving prescription reimbursement under a state or federally funded insurance program.

TAGS:bipolar mania Epilepsy 

<<< Thank you for your visit >>>

Learn about Depakote® (divalproex sodium), a prescription add-on medication for epilepsy and acute bipolar mania. See if Depakote is right for you.

Hot Websites